» Articles » PMID: 36692677

Optimization of Long-range PCR Protocol to Prepare Filaggrin Exon 3 Libraries for PacBio Long-read Sequencing

Abstract

Background: The filaggrin (FLG) protein, encoded by the FLG gene, is an intermediate filament-associated protein that plays a crucial role in the terminal stages of human epidermal differentiation. Loss-of-function mutations in the FLG exon 3 have been associated with skin diseases. The identification of causative mutations is challenging, due to the high sequence homology within its exon 3 (12,753 bp), which includes 10 to 12 filaggrin tandem repeats. With this study we aimed to obtain the whole FLG exon 3 sequence through PacBio technology, once 13-kb amplicons have been generated.

Methods And Results: For the preparation of SMRTbell libraries to be sequenced using PacBio technology, we focused on optimizing a 2-step long-range PCR protocol to generate 13-kb amplicons covering the whole FLG exon 3 sequence. The performance of three long-range DNA polymerases was assessed in an attempt to improve the PCR conditions required for the enzymes to function properly. We focused on optimization of the input template DNA concentration and thermocycling parameters to correctly amplify the entire FLG exon 3 sequence, minimizing non-specific amplification.

Conclusions: Taken together, our findings suggested that the PrimeSTAR protocol is suitable for producing the amplicons of the 13-kb FLG whole exon 3 to prepare SMRTbell libraries. We suggest that sequencing the generated amplicons may be useful for identifying LoF variants that are causative of the patients' disorders.

Citing Articles

Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis.

Bellinato F, Gisondi P, Medori M, Maltese P, Cristofoli F, Mareso C Arch Dermatol Res. 2024; 316(8):606.

PMID: 39251451 DOI: 10.1007/s00403-024-03273-w.


Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort.

Virolainen S, Satish L, Biagini J, Chaib H, Chang W, Dexheimer P JCI Insight. 2024; 9(9).

PMID: 38564302 PMC: 11141906. DOI: 10.1172/jci.insight.178258.


Characterization and genome-informatic analysis of a novel lytic mendocina phage vB_PmeS_STP12 suitable for phage therapy pseudomonas or biocontrol.

Usman S, Christina E Mol Biol Rep. 2024; 51(1):419.

PMID: 38483683 DOI: 10.1007/s11033-024-09362-3.


Towards a Long-Read Sequencing Approach for the Molecular Diagnosis of RPGR Genetic Variants.

Bonetti G, Cozza W, Bernini A, Kaftalli J, Mareso C, Cristofoli F Int J Mol Sci. 2023; 24(23).

PMID: 38069202 PMC: 10706286. DOI: 10.3390/ijms242316881.


Improving Yields in Multi-analyte Extractions by Utilizing Post-homogenized Tissue Debris.

Petersons A, Carlson J, Mathieson W J Histochem Cytochem. 2023; 71(5):273-288.

PMID: 37119238 PMC: 10227881. DOI: 10.1369/00221554231172823.

References
1.
Smith F, Irvine A, Terron-Kwiatkowski A, Sandilands A, Campbell L, Zhao Y . Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006; 38(3):337-42. DOI: 10.1038/ng1743. View

2.
Sandilands A, Sutherland C, Irvine A, McLean W . Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009; 122(Pt 9):1285-94. PMC: 2721001. DOI: 10.1242/jcs.033969. View

3.
Steinert P, Cantieri J, Teller D, Dale B . Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci U S A. 1981; 78(7):4097-101. PMC: 319733. DOI: 10.1073/pnas.78.7.4097. View

4.
Jensen J, Proksch E . The skin's barrier. G Ital Dermatol Venereol. 2009; 144(6):689-700. View

5.
Furue M . Regulation of Filaggrin, Loricrin, and Involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: Pathogenic Implications in Atopic Dermatitis. Int J Mol Sci. 2020; 21(15). PMC: 7432778. DOI: 10.3390/ijms21155382. View